India Women Health Market Trends, Sales Performance, Procedure Volume, Healthcare Spending, Technology Adoption, Reimbursement Analysis, Competitive Landscape, and Growth Outlook

Revenue, 2025

USD 2.43 Bn

Forecast Year, 2035

USD 4.83 Mn

CAGR, 2026 - 2035

7.1%

Report Coverage

India

The India women health market size was evaluated at USD 2.43 billion in 2025 and is expected to grow around USD 4.83 billion by 2035, registering a CAGR of 7.1% from 2026 to 2035. The market in India is mainly driven by growing health awareness, government programs, and the rapid adoption of digital health services.

India Women Health Market Statical Scope

The market is significant as it provides for a large and rapidly expanding population while filling essential gaps in preventive care, maternal assistance, and overall wellness. Changing lifestyles and urban living are driving the need for specialized healthcare. More women in cities are becoming financially independent, which boosts the demand for personalized, convenient, and high-quality health products. Improved access to smartphones and the internet helps digital health platforms to connect with remote areas. These platforms assist in tracking menstrual cycles, providing online consultations, and educating women about reproductive health.

The focus of the market is shifting from basic emergency care to disease prevention and mental health support, with preventive care now being the largest segment in this transition. Women play a significant role in family caregiving, and improving their health positively impacts the health and nutrition of children and entire families.

India Women Health Market, By Application, 2025 (%)

• Hormonal Infertility - The hormonal infertility segment, with a share of 19% in 2025, plays a vital role in the women's health market in India, as endocrine disorders and ovulatory issues impact a large and increasing number of Indian women.
• Contraceptives - The contraceptives segment, with a share of 23% in 2025, is the top revenue-generating area in the women's health market in India, as it meets essential family planning needs, protects maternal health, and responds to the growing demand for birth spacing.
• Polycystic Ovary Syndrome (PCOS) - The Polycystic Ovary Syndrome (PCOS) segment, with a share of 22% in 2025, is a crucial component of the women's health market in India due to its high prevalence, extensive long-term care requirements, and increasing demand for specialized wellness products.

India Women Health Market, By Drug Class, 2025 (%)

• Hormonal Therapies - The hormonal therapies segment, with a share of 28% in 2025, accounts for the largest revenue share in the women's health market in India, as it offers ongoing management for common issues like contraception, menopause, and hormonal disorders.
• Bone Health Agents - The Bone Health Agents segment, with a share of 12% in 2025, is a rapidly growing and important part of the women's health market in India, driven by a significant rise in osteoporosis and widespread nutritional deficiencies among older and postmenopausal women.
• Fertility Agents - The Fertility Agents segment, with a share of 18% in 2025, which includes ovulation stimulants, hormonal regulators, and specialized injectables for assisted reproductive technology (ART), is crucial to the women's health market in India due to increasing clinical demand, changing demographics, and rapid commercial growth.

India Women Health Market, By Age, 2025 (%)

• 50 Years & Above - The segment for women aged 50 and above, with a share of 31% in 2025, is rapidly growing in the women's health market in India, driven by a significant increase in the aging female population and a rising need for specialized mid-life care.
• Below 50 Years - The segment for women below 50 years, with a share of 69% in 2025, holds the largest and most significant share of the women's health market in India, as it covers essential reproductive years, high-demand preventive care, and increasing rates of lifestyle-related endocrine disorders.

Competitive Landscape

The women's health and wellness market in India is driven by leading domestic pharmaceutical firms and healthcare providers that deliver specialized therapeutics, diagnostics, and wellness products. There is an increase in health awareness, digital health usage, and a strong demand for natural and preventive care.

• Mankind Pharma concentrates on fertility and reproductive health, with key products like Prega News (pregnancy test kits), Fertisure-F (fertility support), and Unwanted-72 (emergency contraception).
• Lupin, through its Lupin Femina division, focuses on gynecology, hormonal management, and contraceptive products.
• Zydus Lifesciences, under the Zydus Gynnext division, specializes in pregnancy support and antenatal care products.
• Torrent Pharmaceuticals has broadened its women's health medicine offerings through strategic acquisitions, including those from Elder Pharma.
• Apollo Hospitals provides extensive maternal care, gynecology clinics, and specialized reproductive treatments.
• Fortis Healthcare and Max Healthcare offer advanced obstetric services, cancer screenings, and specialized women's wellness clinics.
• Dabur India and The Himalaya Wellness Company provide natural and herbal solutions for hormonal balance, menstrual health, and overall wellness.

Segments Covered in the Report

By Application

• Hormonal Infertility
• Contraceptives
• Polycystic Ovary Syndrome (PCOS)
• Endometriosis & Uterine Fibroids
• Postmenopausal Osteoporosis
• Menopause

By Drug Class

• Hormonal Therapies
• Bone Health Agents
• Fertility Agents
• GnRH Modulators
• Pain and Symptom Management
• Metabolic Agents
• Others

By Age

• 50 Years & Above
• Below 50 Years